Open AccessMP80-01 PHOSPHODIESTERASE TYPE 5 INHIBITOR USE IS NOT ASSOCIATED WITH BIOCHEMICAL RECURRENCE AFTER DEFINITIVE THERAPY FOR PROSTATE CANCER
Author(s) -
Michael Leapman,
Hao G. Nguyen,
Janet E. Cowan,
Sima P. Porten,
Maxwell V. Meng,
Matthew R. Cooperberg,
Peter R. Carroll
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.2033
Subject(s) - medicine , prostate cancer , biochemical recurrence , androgen deprivation therapy , prostatectomy , cancer , radiation therapy , vardenafil , gynecology , oncology , erectile dysfunction , tadalafil
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom